Compare · DMAQ vs SONO
DMAQ vs SONO
Side-by-side comparison of Deep Medicine Acquisition Corp. (DMAQ) and Sonos Inc. (SONO): market cap, price performance, sector, and recent activity on the wire.
Summary
- DMAQ operates in Industrials, while SONO operates in Consumer Staples - the two are in different parts of the market.
- SONO is the larger of the two at $2.94B, about 18.2x DMAQ ($162.0M).
- SONO has hit the wire 1 time in the past 4 weeks while DMAQ has been quiet.
- SONO has more recent analyst coverage (12 ratings vs 0 for DMAQ).
- Company
- Deep Medicine Acquisition Corp.
- Sonos Inc.
- Price
- $3.20-62.31%
- $14.74+2.25%
- Market cap
- $162.0M
- $2.94B
- 1M return
- -
- +11.08%
- 1Y return
- -
- +60.74%
- Industry
- Consumer Electronics/Appliances
- Consumer Electronics/Appliances
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2021
- 2018
- News (4w)
- 0
- 1
- Recent ratings
- 0
- 12
Deep Medicine Acquisition Corp.
Deep Medicine Acquisition Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It focuses on identifying businesses in the healthcare industry. The company was incorporated in 2020 and is based in New York, New York.
Sonos Inc.
Sonos, Inc., together with its subsidiaries, designs, develops, manufactures, and sells multi-room audio products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company provides wireless speakers, home theater speakers, components, and accessories. It offers its products through approximately 10,000 third-party retail stores, including custom installers of home audio systems; and e-commerce retailers, as well as through its Website sonos.com. The company was formerly known as Rincon Audio, Inc. and changed its name to Sonos, Inc. in May 2004. Sonos, Inc. was founded in 2002 and is headquartered in Santa Barbara, California.
Latest DMAQ
- SEC Form PRE 14A filed by Deep Medicine Acquisition Corp.
- SEC Form 10-Q filed by Deep Medicine Acquisition Corp.
- SEC Form S-1 filed by Deep Medicine Acquisition Corp.
- SEC Form SC 13G/A filed by Deep Medicine Acquisition Corp. (Amendment)
- Deep Medicine Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement
- Deep Medicine Acquisition Corp. filed SEC Form 8-K: Leadership Update, Completion of Acquisition or Disposition of Assets, Entry into a Material Definitive Agreement, Change in Shell Company Status, Financial Statements and Exhibits, Unregistered Sales of Equity Securities, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure
- SEC Form 3 filed by new insider Russell Riley
- SEC Form 3 filed by new insider Jones Lindsay
- New insider Jones Christopher Jon claimed ownership of 1,931,983 shares and claimed ownership of 860,082 units of Class B Common Stock (SEC Form 3)
- SEC Form 3 filed by new insider Redmer A.J.
Latest SONO
- Sonos Announces Date for Second Quarter Fiscal 2026 Financial Results and Conference Call
- Amendment: SEC Form SCHEDULE 13G/A filed by Sonos Inc.
- Large owner Coliseum Capital Management, Llc bought $3,068,690 worth of shares (228,920 units at $13.41) (SEC Form 4)
- Large owner Coliseum Capital Management, Llc bought $12,959,400 worth of shares (920,000 units at $14.09) (SEC Form 4)
- Director Genachowski Julius gifted 15,427 shares and received a gift of 15,427 shares, decreasing direct ownership by 22% to 53,775 units (SEC Form 4)
- Sonos Returns to the System That Built the Brand with Two Essential Speakers That Deliver Effortless Sound Throughout the Home
- Director Mildenhall Jonathan was granted 12,725 shares, increasing direct ownership by 46% to 40,272 units (SEC Form 4)
- Director Kennedy Joseph Jude was granted 12,725 shares, increasing direct ownership by 776% to 14,364 units (SEC Form 4)
- Director Genachowski Julius was granted 17,497 shares, increasing direct ownership by 34% to 69,202 units (SEC Form 4)
- Director Fields Mandy J was granted 12,725 shares, increasing direct ownership by 776% to 14,364 units (SEC Form 4)